Performance analysis of OS Therapies (OSTX)
Annual Return
Since Aug 1, 2024, OSTX has had an average annual return of -22.77%, underperforming the benchmark SPY, which returned +18.61% annual.
| 2026 | 2025 | 2024 | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| +7.85% | -67.29% | +70.52% |
Monthly Return
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Annually Total |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | -2.87% | +8.10% | -4.08% | +20.56% | +25.88% | -11.21% | -20.53% | +7.85% | |||||
| 2025 | -57.01% | -10.33% | -6.68% | +31.83% | -24.63% | +22.87% | -5.31% | +34.26% | -17.99% | -5.11% | -3.77% | -21.78% | -67.29% |
| 2024 | +64.94% | -32.37% | -6.43% | -18.32% | +100% | +70.52% |
Drawdown analysis of OS Therapies (OSTX)
The maximum drawdown for the OSTX was -78.30%, occurring on Apr 10, 2025. This drawdown has not yet recovered.
The current OSTX drawdown is -70.74%.
Since Aug 1, 2024 OSTX has experienced the following drawdowns:
- 50% or more: 2 times
- 40% or more: 2 times
- 30% or more: 3 times
- 20% or more: 4 times
- 10% or more: 5 times
| Depth | Start | To Bottom | Bottom | To Recover | End | Total |
|---|---|---|---|---|---|---|
| -78.30% | Dec 27, 2024 | 70 | Apr 10, 2025 | Ongoing | Ongoing | Ongoing |
| -59.12% | Aug 9, 2024 | 72 | Nov 20, 2024 | 15 | Dec 12, 2024 | 87 |
| -32.29% | Dec 12, 2024 | 1 | Dec 13, 2024 | 2 | Dec 17, 2024 | 3 |
| -28.75% | Aug 2, 2024 | 1 | Aug 5, 2024 | 4 | Aug 9, 2024 | 5 |
| -19.74% | Dec 17, 2024 | 4 | Dec 23, 2024 | 2 | Dec 26, 2024 | 6 |